Clinical Trial Update: Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 long-term study in patients with chronic kidney disease and hyperphosphatemia on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease, Renal Dialysis | Phase 3 | Status: COMPLETED